Author correction to ‘Co-delivery of nigericin and decitabine using hexahistidine-metal nanocarriers for pyroptosis-induced immunotherapeutics’ [Acta Pharm Sin B 12 (2022) 4458–4471]
Qiang Niu,
Yu Liu,
Yujing Zheng,
Ziwei Tang,
Yuna Qian,
Ruogu Qi,
Jianliang Shen,
Ping Zhao
Affiliations
Qiang Niu
School of Chemistry and Chemical Engineering, Guangdong Pharmaceutical University, Guangzhou 510006, China
Yu Liu
State Key Laboratory of Ophthalmology, Optometry and Vision Science, School of Ophthalmology and Optometry, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou 325027, China
Yujing Zheng
State Key Laboratory of Ophthalmology, Optometry and Vision Science, School of Ophthalmology and Optometry, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou 325027, China
Ziwei Tang
School of Chemistry and Chemical Engineering, Guangdong Pharmaceutical University, Guangzhou 510006, China
Yuna Qian
State Key Laboratory of Ophthalmology, Optometry and Vision Science, School of Ophthalmology and Optometry, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou 325027, China; Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou 325001, China
Ruogu Qi
School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China; Corresponding authors.
Jianliang Shen
State Key Laboratory of Ophthalmology, Optometry and Vision Science, School of Ophthalmology and Optometry, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou 325027, China; Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou 325001, China; Corresponding authors.
Ping Zhao
School of Chemistry and Chemical Engineering, Guangdong Pharmaceutical University, Guangzhou 510006, China; Corresponding authors.
